186 related articles for article (PubMed ID: 33837042)
1. Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade.
Saida Y; Brender JR; Yamamoto K; Mitchell JB; Krishna MC; Kishimoto S
Cancer Res; 2021 Jul; 81(13):3693-3705. PubMed ID: 33837042
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Bissonnette RP; Cesario RM; Goodenow B; Shojaei F; Gillings M
BMC Cancer; 2021 Aug; 21(1):969. PubMed ID: 34461854
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
[TBL] [Abstract][Full Text] [Related]
4. MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy.
Jiang X; Dudzinski S; Beckermann KE; Young K; McKinley E; J McIntyre O; Rathmell JC; Xu J; Gore JC
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581044
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment.
Wang HQ; Mulford IJ; Sharp F; Liang J; Kurtulus S; Trabucco G; Quinn DS; Longmire TA; Patel N; Patil R; Shirley MD; Chen Y; Wang H; Ruddy DA; Fabre C; Williams JA; Hammerman PS; Mataraza J; Platzer B; Halilovic E
Cancer Res; 2021 Jun; 81(11):3079-3091. PubMed ID: 33504557
[TBL] [Abstract][Full Text] [Related]
6. Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.
Kato R; Haratani K; Hayashi H; Sakai K; Sakai H; Kawakami H; Tanaka K; Takeda M; Yonesaka K; Nishio K; Nakagawa K
Br J Cancer; 2021 Mar; 124(5):914-924. PubMed ID: 33299131
[TBL] [Abstract][Full Text] [Related]
7. Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent manner.
Muramatsu T; Noguchi T; Sugiyama D; Kanada Y; Fujimaki K; Ito S; Gotoh M; Nishikawa H
Int Immunol; 2021 Jan; 33(1):39-48. PubMed ID: 32729901
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.
Shields BD; Koss B; Taylor EM; Storey AJ; West KL; Byrum SD; Mackintosh SG; Edmondson R; Mahmoud F; Shalin SC; Tackett AJ
Cancer Res; 2019 Mar; 79(6):1113-1123. PubMed ID: 30674537
[TBL] [Abstract][Full Text] [Related]
9. Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response.
Sato Y; Fu Y; Liu H; Lee MY; Shaw MH
BMC Cancer; 2021 Nov; 21(1):1222. PubMed ID: 34774008
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
[TBL] [Abstract][Full Text] [Related]
11. 13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors.
Saito K; Matsumoto S; Takakusagi Y; Matsuo M; Morris HD; Lizak MJ; Munasinghe JP; Devasahayam N; Subramanian S; Mitchell JB; Krishna MC
Clin Cancer Res; 2015 Nov; 21(22):5073-81. PubMed ID: 25673698
[TBL] [Abstract][Full Text] [Related]
12. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
[TBL] [Abstract][Full Text] [Related]
13. RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer.
Yamamoto Y; Shimada S; Akiyama Y; Tsukihara S; Sugimoto R; Kabashima A; Tokunaga M; Kinugasa Y; Kawakami Y; Tanaka S
J Gastroenterol; 2023 Jun; 58(6):540-553. PubMed ID: 36859628
[TBL] [Abstract][Full Text] [Related]
14. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
[TBL] [Abstract][Full Text] [Related]
15. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.
Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z
Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956
[TBL] [Abstract][Full Text] [Related]
16. Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.
Bohndiek SE; Kettunen MI; Hu DE; Brindle KM
Cancer Res; 2012 Feb; 72(4):854-64. PubMed ID: 22223844
[TBL] [Abstract][Full Text] [Related]
17. PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses.
Tian H; Kang Y; Song X; Xu Y; Chen H; Gong X; Zhang W; Xu Y; Xia X; Gao X; Yao W
Cancer Lett; 2020 Apr; 476():170-182. PubMed ID: 32092355
[TBL] [Abstract][Full Text] [Related]
18. Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.
Fiegle E; Doleschel D; Koletnik S; Rix A; Weiskirchen R; Borkham-Kamphorst E; Kiessling F; Lederle W
Neoplasia; 2019 Sep; 21(9):932-944. PubMed ID: 31412307
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy.
Wang Z; Little N; Chen J; Lambesis KT; Le KT; Han W; Scott AJ; Lu J
Nat Nanotechnol; 2021 Oct; 16(10):1130-1140. PubMed ID: 34385682
[TBL] [Abstract][Full Text] [Related]
20. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
